Longboard Pharmaceuticals Inc. (LBPH)

The total asset value of Longboard Pharmaceuticals Inc. (LBPH) stood at $ 87 Mln as on 31-Mar-23

The share price of Longboard Pharmaceuticals Inc. (LBPH) is $3.96 (NASDAQ) as of 04-Dec-2023 16:02 EST. Longboard Pharmaceuticals Inc. (LBPH) has given a return of -23.77% in the last 1 years.

Longboard Pharmaceuticals Inc. (LBPH) has a market capitalisation of $ 165 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

The P/B ratio of Longboard Pharmaceuticals Inc. (LBPH) is 0.85 times as on 02-Jun-2023, a -0.67% premium to its peers’ median range of 2.54 times.

Since, TTM earnings of Longboard Pharmaceuticals Inc. (LBPH) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Longboard Pharmaceuticals Inc. (LBPH) and enter the required number of quantities and click on buy to purchase the shares of Longboard Pharmaceuticals Inc. (LBPH).

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

The CEO & director of Mr. Kevin R. Lind. is Longboard Pharmaceuticals Inc. (LBPH), and CFO & Sr. VP is Ms. Brandi L. Roberts CPA, M.B.A..

The promoters of Longboard Pharmaceuticals Inc. (LBPH) have pledged 0% of the total equity as on Mar-23.

Some of the close peers are:

No, TTM profit after tax of Longboard Pharmaceuticals Inc. (LBPH) was $-34 Mln.